SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-23-221648
Filing Date
2023-08-28
Accepted
2023-08-25 17:36:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d543736d424b3.htm 424B3 133908
2 GRAPHIC g543736g15w44.jpg GRAPHIC 41750
  Complete submission text file 0001193125-23-221648.txt   188250
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-274010 | Film No.: 231209465
SIC: 2834 Pharmaceutical Preparations